Eric Easom - Oct 27, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Stock symbol
ANTX
Transactions as of
Oct 27, 2022
Transactions value $
-$39,582
Form type
4
Date filed
10/28/2022, 08:27 PM
Previous filing
Oct 26, 2022
Next filing
Nov 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$14.2K -924 -12.3% $15.36 6.59K Oct 27, 2022 Direct F1
transaction ANTX Common Stock Sale -$25.4K -1.68K -25.54% $15.09 4.91K Oct 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.